Icecure Medical LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Shad Good, VP, Sales for North America of IceCure Medical Ltd., received 131,483 shares of common stock on August 14, 2026.
NASDAQ
Tlalit Bussi Tel-Tzure, VP, BD & Global Marketing of IceCure Medical Ltd., received 101,483 shares of common stock on August 14, 2026.
NASDAQ
Shay Levav, Chief Operating Officer of IceCure Medical Ltd., received 141,483 shares of common stock on August 14, 2026.
NASDAQ
Merav Nir Dotan, VP, Human Resources of IceCure Medical Ltd., received 73,890 shares of common stock on August 14, 2026.
NASDAQ
Meir Peleg, Chief Financial Officer of IceCure Medical Ltd., received 181,483 shares of common stock on August 14, 2026.
NASDAQ
Vincent Chun Hung Chan, a Director of IceCure Medical Ltd., reported multiple transactions in common stock on August 12, 2026.
NASDAQ
Naum Muchnik, VP of R&D and Engineering at IceCure Medical Ltd., has filed an exit Form 4, reporting his departure and cessation of Section 16 reporting obligations.
NASDAQ
Ronen Tsimerman has filed an exit Form 4, indicating he is no longer the Chief Financial Officer of IceCure Medical Ltd. as of May 17, 2026.